Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Aug 1;349(Pt 3):717–728. doi: 10.1042/bj3490717

Structure-function relationships in novel peptide dodecamerswith broad-spectrum bactericidal and endotoxin-neutralizing activities.

K H Mayo 1, J Haseman 1, H C Young 1, J W Mayo 1
PMCID: PMC1221198  PMID: 10903132

Abstract

A series of designed peptide 33-mers (betapep peptides) areknown to be bactericidal [Mayo, Haseman, Ilyina and Gray (1998)Biochim. Biophys. Acta 1425, 81-92]. Here dodecapeptides (SC-1-SC-8), which 'walk through' the sequence ofbetapep-25, were investigated for their ability to kill Gram-negativeand -positive bacteria and to neutralize endotoxin. SC-4 (KLFKRHLKWKI I-NH(2); the -NH(2) at the right of each sequenceindicates amidation of the C-terminal carboxylate group) is the mosteffective, more so than betapep-25, at killing Gram-negative bacteriawith nanomolar LD(50) values. Against Gram-positive bacteria,SC-4 also shows good activity with submicromolar LD(50)values. Leakage studies indicate rapid bacterial membrane permeability,with t(1/2) valuesof 10-15 min. SC-4 in the micromolar range also effectivelyneutralizes endotoxin and is not haemolytic below 10(-4)M. For all SC peptides, CD and NMR data indicate the presence of both 3(10)- and alpha-helix. For SC-4, nuclear-Overhauser-effect-based computational modelling yields an amphipathic helix with K1, K4,R5, and K8 arrayed on the same face (K is lysine, R is arginine).Activity differences among SC peptides and single-site variants of SC-4allow some structure-function relationships to be deduced.Relative to other known bactericidal peptides in the linear peptide,helix-forming category, SC-4 is the most potent broad-spectrumantibacterial identified to date. The present study contributes to thedevelopment of agents involved in combating the ever-recurring problemof drug-resistant micro-organisms.

Full Text

The Full Text of this article is available as a PDF (352.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agerberth B., Lee J. Y., Bergman T., Carlquist M., Boman H. G., Mutt V., Jörnvall H. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem. 1991 Dec 18;202(3):849–854. doi: 10.1111/j.1432-1033.1991.tb16442.x. [DOI] [PubMed] [Google Scholar]
  2. Alvarez-Bravo J., Kurata S., Natori S. Mode of action of an antibacterial peptide, KLKLLLLLKLK-NH2. J Biochem. 1995 Jun;117(6):1312–1316. doi: 10.1093/oxfordjournals.jbchem.a124860. [DOI] [PubMed] [Google Scholar]
  3. Andreu D., Merrifield R. B., Steiner H., Boman H. G. N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties. Biochemistry. 1985 Mar 26;24(7):1683–1688. doi: 10.1021/bi00328a017. [DOI] [PubMed] [Google Scholar]
  4. Andreu D., Rivas L. Animal antimicrobial peptides: an overview. Biopolymers. 1998;47(6):415–433. doi: 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  5. Beamer L. J., Carroll S. F., Eisenberg D. Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science. 1997 Jun 20;276(5320):1861–1864. doi: 10.1126/science.276.5320.1861. [DOI] [PubMed] [Google Scholar]
  6. Darveau R. P., Blake J., Seachord C. L., Cosand W. L., Cunningham M. D., Cassiano-Clough L., Maloney G. Peptides related to the carboxyl terminus of human platelet factor IV with antibacterial activity. J Clin Invest. 1992 Aug;90(2):447–455. doi: 10.1172/JCI115880. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Delaglio F., Grzesiek S., Vuister G. W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995 Nov;6(3):277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
  8. Dyson H. J., Rance M., Houghten R. A., Wright P. E., Lerner R. A. Folding of immunogenic peptide fragments of proteins in water solution. II. The nascent helix. J Mol Biol. 1988 May 5;201(1):201–217. doi: 10.1016/0022-2836(88)90447-0. [DOI] [PubMed] [Google Scholar]
  9. Ehrenstein G., Lecar H. Electrically gated ionic channels in lipid bilayers. Q Rev Biophys. 1977 Feb;10(1):1–34. doi: 10.1017/s0033583500000123. [DOI] [PubMed] [Google Scholar]
  10. Gazit E., Boman A., Boman H. G., Shai Y. Interaction of the mammalian antibacterial peptide cecropin P1 with phospholipid vesicles. Biochemistry. 1995 Sep 12;34(36):11479–11488. doi: 10.1021/bi00036a021. [DOI] [PubMed] [Google Scholar]
  11. Gray B. H., Haseman J. R., Mayo K. H. B/PI-derived synthetic peptides: synergistic effects in tethered bactericidal and endotoxin neutralizing peptides. Biochim Biophys Acta. 1995 May 11;1244(1):185–190. doi: 10.1016/0304-4165(95)00004-u. [DOI] [PubMed] [Google Scholar]
  12. Greenfield N., Fasman G. D. Computed circular dichroism spectra for the evaluation of protein conformation. Biochemistry. 1969 Oct;8(10):4108–4116. doi: 10.1021/bi00838a031. [DOI] [PubMed] [Google Scholar]
  13. Hanzawa H., Shimada I., Kuzuhara T., Komano H., Kohda D., Inagaki F., Natori S., Arata Y. 1H nuclear magnetic resonance study of the solution conformation of an antibacterial protein, sapecin. FEBS Lett. 1990 Sep 3;269(2):413–420. doi: 10.1016/0014-5793(90)81206-4. [DOI] [PubMed] [Google Scholar]
  14. Hill C. P., Yee J., Selsted M. E., Eisenberg D. Crystal structure of defensin HNP-3, an amphiphilic dimer: mechanisms of membrane permeabilization. Science. 1991 Mar 22;251(5000):1481–1485. doi: 10.1126/science.2006422. [DOI] [PubMed] [Google Scholar]
  15. Hoess A., Watson S., Siber G. R., Liddington R. Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J. 1993 Sep;12(9):3351–3356. doi: 10.1002/j.1460-2075.1993.tb06008.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Holak T. A., Engström A., Kraulis P. J., Lindeberg G., Bennich H., Jones T. A., Gronenborn A. M., Clore G. M. The solution conformation of the antibacterial peptide cecropin A: a nuclear magnetic resonance and dynamical simulated annealing study. Biochemistry. 1988 Oct 4;27(20):7620–7629. doi: 10.1021/bi00420a008. [DOI] [PubMed] [Google Scholar]
  17. Ilyina E., Roongta V., Mayo K. H. NMR structure of a de novo designed, peptide 33mer with two distinct, compact beta-sheet folds. Biochemistry. 1997 Apr 29;36(17):5245–5250. doi: 10.1021/bi963064o. [DOI] [PubMed] [Google Scholar]
  18. Johnson J. R., Brown J. J. A novel multiply primed polymerase chain reaction assay for identification of variant papG genes encoding the Gal(alpha 1-4)Gal-binding PapG adhesins of Escherichia coli. J Infect Dis. 1996 Apr;173(4):920–926. doi: 10.1093/infdis/173.4.920. [DOI] [PubMed] [Google Scholar]
  19. Johnson J. R., Brown J. J. Defining inoculation conditions for the mouse model of ascending urinary tract infection that avoid immediate vesicoureteral reflux yet produce renal and bladder infection. J Infect Dis. 1996 Mar;173(3):746–749. doi: 10.1093/infdis/173.3.746. [DOI] [PubMed] [Google Scholar]
  20. Johnson W. C., Jr Protein secondary structure and circular dichroism: a practical guide. Proteins. 1990;7(3):205–214. doi: 10.1002/prot.340070302. [DOI] [PubMed] [Google Scholar]
  21. Kawano K., Yoneya T., Miyata T., Yoshikawa K., Tokunaga F., Terada Y., Iwanaga S. Antimicrobial peptide, tachyplesin I, isolated from hemocytes of the horseshoe crab (Tachypleus tridentatus). NMR determination of the beta-sheet structure. J Biol Chem. 1990 Sep 15;265(26):15365–15367. [PubMed] [Google Scholar]
  22. Kelly C. J., Cech A. C., Argenteanu M., Gallagher H., Shou J., Minnard E., Daly J. M. Role of bactericidal permeability-increasing protein in the treatment of gram-negative pneumonia. Surgery. 1993 Aug;114(2):140–146. [PubMed] [Google Scholar]
  23. Lee J. Y., Boman A., Sun C. X., Andersson M., Jörnvall H., Mutt V., Boman H. G. Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A. 1989 Dec;86(23):9159–9162. doi: 10.1073/pnas.86.23.9159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Lehrer R. I., Ganz T., Selsted M. E. Defensins: endogenous antibiotic peptides of animal cells. Cell. 1991 Jan 25;64(2):229–230. doi: 10.1016/0092-8674(91)90632-9. [DOI] [PubMed] [Google Scholar]
  25. Maloy W. L., Kari U. P. Structure-activity studies on magainins and other host defense peptides. Biopolymers. 1995;37(2):105–122. doi: 10.1002/bip.360370206. [DOI] [PubMed] [Google Scholar]
  26. Marion D., Zasloff M., Bax A. A two-dimensional NMR study of the antimicrobial peptide magainin 2. FEBS Lett. 1988 Jan 18;227(1):21–26. doi: 10.1016/0014-5793(88)81405-4. [DOI] [PubMed] [Google Scholar]
  27. Matsuyama K., Natori S. Purification of three antibacterial proteins from the culture medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina. J Biol Chem. 1988 Nov 15;263(32):17112–17116. [PubMed] [Google Scholar]
  28. Matsuzaki K., Nakamura A., Murase O., Sugishita K., Fujii N., Miyajima K. Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry. 1997 Feb 25;36(8):2104–2111. doi: 10.1021/bi961870p. [DOI] [PubMed] [Google Scholar]
  29. Mayo K. H., Haseman J., Ilyina E., Gray B. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities. Biochim Biophys Acta. 1998 Sep 16;1425(1):81–92. doi: 10.1016/s0304-4165(98)00053-1. [DOI] [PubMed] [Google Scholar]
  30. Mayo K. H., Ilyina E., Park H. A recipe for designing water-soluble, beta-sheet-forming peptides. Protein Sci. 1996 Jul;5(7):1301–1315. doi: 10.1002/pro.5560050709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Millhauser G. L. Views of helical peptides: a proposal for the position of 3(10)-helix along the thermodynamic folding pathway. Biochemistry. 1995 Mar 28;34(12):3873–3877. doi: 10.1021/bi00012a001. [DOI] [PubMed] [Google Scholar]
  32. Morrison D. C., Jacobs D. M. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry. 1976 Oct;13(10):813–818. doi: 10.1016/0019-2791(76)90181-6. [DOI] [PubMed] [Google Scholar]
  33. Oren Z., Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers. 1998;47(6):451–463. doi: 10.1002/(SICI)1097-0282(1998)47:6<451::AID-BIP4>3.0.CO;2-F. [DOI] [PubMed] [Google Scholar]
  34. Pouny Y., Rapaport D., Mor A., Nicolas P., Shai Y. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochemistry. 1992 Dec 15;31(49):12416–12423. doi: 10.1021/bi00164a017. [DOI] [PubMed] [Google Scholar]
  35. Rustici A., Velucchi M., Faggioni R., Sironi M., Ghezzi P., Quataert S., Green B., Porro M. Molecular mapping and detoxification of the lipid A binding site by synthetic peptides. Science. 1993 Jan 15;259(5093):361–365. doi: 10.1126/science.8420003. [DOI] [PubMed] [Google Scholar]
  36. Schlievert P. M., Blomster D. A. Production of staphylococcal pyrogenic exotoxin type C: influence of physical and chemical factors. J Infect Dis. 1983 Feb;147(2):236–242. doi: 10.1093/infdis/147.2.236. [DOI] [PubMed] [Google Scholar]
  37. Selsted M. E., Harwig S. S. Determination of the disulfide array in the human defensin HNP-2. A covalently cyclized peptide. J Biol Chem. 1989 Mar 5;264(7):4003–4007. [PubMed] [Google Scholar]
  38. Siefferman C. M., Regelmann W. E., Gray B. H. Pseudomonas aeruginosa variants isolated from patients with cystic fibrosis are killed by a bactericidal protein from human polymorphonuclear leukocytes. Infect Immun. 1991 Jun;59(6):2152–2157. doi: 10.1128/iai.59.6.2152-2157.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Sreerama N., Woody R. W. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal Biochem. 1993 Feb 15;209(1):32–44. doi: 10.1006/abio.1993.1079. [DOI] [PubMed] [Google Scholar]
  40. Warren H. S., Novitsky T. J., Bucklin A., Kania S. A., Siber G. R. Endotoxin neutralization with rabbit antisera to Escherichia coli J5 and other gram-negative bacteria. Infect Immun. 1987 Jul;55(7):1668–1673. doi: 10.1128/iai.55.7.1668-1673.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Waterhous D. V., Johnson W. C., Jr Importance of environment in determining secondary structure in proteins. Biochemistry. 1994 Mar 1;33(8):2121–2128. doi: 10.1021/bi00174a019. [DOI] [PubMed] [Google Scholar]
  42. Wishart D. S., Sykes B. D., Richards F. M. The chemical shift index: a fast and simple method for the assignment of protein secondary structure through NMR spectroscopy. Biochemistry. 1992 Feb 18;31(6):1647–1651. doi: 10.1021/bi00121a010. [DOI] [PubMed] [Google Scholar]
  43. Young N. S., Levin J., Prendergast R. A. An invertebrate coagulation system activated by endotoxin: evidence for enzymatic mediation. J Clin Invest. 1972 Jul;51(7):1790–1797. doi: 10.1172/JCI106980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Zasloff M., Martin B., Chen H. C. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci U S A. 1988 Feb;85(3):910–913. doi: 10.1073/pnas.85.3.910. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES